Literature DB >> 15927645

Achalasia.

Todd A Woltman1, Carlos A Pellegrini, Brant K Oelschlager.   

Abstract

Surgical therapy (Heller myotomy) is the most effective treatment to relieve dysphagia associated with achalasia. The advent of minimally invasive techniques, specifically the laparoscopic approach, significantly reduced the morbidity of surgical therapy, making it the procedure of choice for most patients who have achalasia. Pneumatic dilatation is a viable alternative, though is associated with inferior results and a higher risk of esophageal perforation than surgical therapy. Pharmacotherapy and Botox provide inferior results and should be reserved for temporizing therapy, or for patients who are deemed too frail for surgical intervention. For best results, a laparoscopic myotomy should be carried at least 3 cm onto the stomach, and a partial fundoplication should be performed to reduce the incidence of postoperative GE reflux.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15927645     DOI: 10.1016/j.suc.2005.01.002

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  17 in total

1.  SAGES guidelines for the surgical treatment of esophageal achalasia.

Authors:  Dimitrios Stefanidis; William Richardson; Timothy M Farrell; Geoffrey P Kohn; Vedra Augenstein; Robert D Fanelli
Journal:  Surg Endosc       Date:  2011-11-02       Impact factor: 4.584

2.  Novel mechanism for impaired nitrergic relaxation in achalasia.

Authors:  G E Boeckxstaens
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

3.  Esophagectomy for end stage achalasia.

Authors:  Stephen M Glatz; J David Richardson
Journal:  J Gastrointest Surg       Date:  2007-07-11       Impact factor: 3.452

4.  Laparoscopic esophagogastroplasty: a minimally invasive alternative to esophagectomy in the surgical management of megaesophagus with axis deviation.

Authors:  Anil K Agarwal; Amit Javed
Journal:  Surg Endosc       Date:  2013-01-11       Impact factor: 4.584

5.  Gastrointestinal Uses of Botulinum Toxin.

Authors:  Maria Cariati; Maria Michela Chiarello; Marco Cannistra'; Maria Antonietta Lerose; Giuseppe Brisinda
Journal:  Handb Exp Pharmacol       Date:  2021

6.  Improvement of respiratory symptoms following Heller myotomy for achalasia.

Authors:  Saurabh Khandelwal; Rebecca Petersen; Roger Tatum; Huseyin Sinan; Daniel Aaronson; Fernando Mier; Ana V Martin; Carlos A Pellegrini; Brant K Oelschlager
Journal:  J Gastrointest Surg       Date:  2010-12-14       Impact factor: 3.452

7.  The cost of laparoscopic myotomy versus pneumatic dilatation for esophageal achalasia.

Authors:  Paul J Karanicolas; Shona E Smith; Richard I Inculet; Richard A Malthaner; Richard P Reynolds; Ron Goeree; Amiram Gafni
Journal:  Surg Endosc       Date:  2007-05-04       Impact factor: 4.584

8.  Laparoscopic Heller's cardiomyotomy: a viable treatment option for sigmoid oesophagus.

Authors:  Karthik Panchanatheeswaran; Rajinder Parshad; Jitender Rohila; Anoop Saraya; Govind K Makharia; Raju Sharma
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-10-12

9.  Laparoscopic Heller's cardiomyotomy in cirrhosis with oesophageal varices.

Authors:  Abhay N Dalvi; Pinky M Thapar; Nitin M Narawane; Rippan N Shukla
Journal:  J Minim Access Surg       Date:  2010-04       Impact factor: 1.407

10.  Defining a learning curve for laparoscopic cardiomyotomy.

Authors:  Brechtje A Grotenhuis; Bas P L Wijnhoven; Glyn G Jamieson; Peter G Devitt; Justin R Bessell; David I Watson
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.